ArticleAdvanced healthcare materials2026
Comparison of Crosslinking Reagents and Their Impacts on Bone Derived ECM Hydrogels.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Extracellular matrix (ECM) derived biomaterials are becoming more prevalent for regenerative medicine applications as they can provide bio-instructive cues to damaged tissues, facilitating constructive remodeling of the injured site. Existing clinical products based on ECM can be found in sheet or powder formats, however recent clinical trials have utilized ECM hydrogels. Further exploration of ECM hydrogels and modulation of their mechanics, degradation and swelling behaviors could provide increased utility of these materials. Mechanical modulation through crosslinking can be achieved through application of chemical reagents such as glutaraldehyde (GA). However long-term effects of GA warrant increased research of alternatives such as the plant-based derivatives genipin (GP) and proanthocyanidins (PA). In this work, crosslinking was confirmed through alterations to the mechanical moduli of bECM hydrogels with both GP and PA conferring significantly increased moduli compared to non-crosslinked controls. In vitro examination determined that cytotoxic effects were observed for PA to SH-SY5Y cells at the concentration used, however no cytotoxicity was observed from PA when tested on L929 cells and primary tenocytes. There was no cytotoxicity observed from GP treatment. Therefore, use of these reagents could provide a further toolkit to manipulate physicochemical properties and increase utility of ECM hydrogels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.